Detalles de la búsqueda
1.
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Br J Haematol
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593353
2.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320176
3.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654660
4.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542108
5.
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Haematologica
; 108(3): 690-704, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35708137
6.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815361
7.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678031
8.
Co-Culture of Mesenchymal Stem Cells and Ligamentocytes on Triphasic Embroidered Poly(L-lactide-co-ε-caprolactone) and Polylactic Acid Scaffolds for Anterior Cruciate Ligament Enthesis Tissue Engineering.
Int J Mol Sci
; 24(7)2023 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37047686
9.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood
; 136(7): 823-830, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496541
10.
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Haematologica
; 106(2): 363-374, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879324
11.
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Haematologica
; 106(12): 3100-3106, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34047178
12.
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT).
Am J Hematol
; 96(1): 40-50, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32944990
13.
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.
Biol Blood Marrow Transplant
; 25(7): 1450-1455, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30876928
14.
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
Biol Blood Marrow Transplant
; 24(7): 1372-1378, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29408334
15.
Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial.
Haematologica
; 108(9): 2520-2525, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779591
16.
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Biol Blood Marrow Transplant
; 23(9): 1491-1497, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28527985
17.
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD.
Biol Blood Marrow Transplant
; 22(3): 462-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26551637
18.
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 172(6): 914-22, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26771088
19.
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Blood
; 123(19): 2960-7, 2014 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24652988
20.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662018